All articles tagged: Malignant neoplasm of cervix uteri, unspecified (C53.9)
HealthDay
08 July at 03.26 PM
Tisotumab Vedotin Efficacious for Recurrent Cervical CancerSecond- or third-line treatment with tisotumab vedotin is efficacious for patients with recurrent cervical cancer, according to a study published in the July 4 issue of the New England Journal of Medicine.Ignace Vergote, M.D., Ph.D., from Universitaire Ziekenhuizen Leuven in Belgium, and colleagues conducted a phase 3, multinational, ope |
|
HealthDay
28 June at 03.02 PM
Survival Improves With Open Hysterectomy for Cervical CancerFor patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally invasive versus open radical hysterectomy, according to a study published online June 25 in the Journal of Clinical Oncology.Pedro T. Ramirez, M.D., from the Methodist Hospital in Houston, and colleagues compared |
|
HealthDay
05 January at 04.32 PM
Atezolizumab Plus Standard Care Improves Survival in Advanced Cervical CancerFor patients with metastatic, persistent, or recurrent cervical cancer, adding atezolizumab to a standard bevacizumab plus platinum regimen significantly improves progression-free and overall survival, according to a study published in the January issue of The Lancet.Ana Oaknin, M.D., from the Vall d'Hebron Institute of Oncology in Barce |
|
HealthDay
30 November at 04.48 PM
Active Surveillance Tied to Higher Long-Term Cervical Cancer RiskUndergoing active surveillance for cervical intraepithelial neoplasia grade 2 (CIN2) is associated with higher long-term risk for cervical cancer compared with that seen for women receiving immediate treatment, according to a study published online Nov. 29 in The BMJ.Kathrine Dyhr Lycke, from Aarhus University in Denmark, and col |
|
HealthDay
14 November at 11.58 PM
Government Housing Assistance May Boost Some Cancer ScreeningReceipt of government housing assistance is associated with increased rates of breast cancer (BC) and colorectal cancer (CRC) screening, according to a study published online Nov. 8 in the American Journal of Preventive Medicine.Jordan Baeker Bispo, Ph.D., from the American Cancer Society in Atlanta, and colleagues used data from |
|
HealthDay
02 November at 03.32 PM
Moderate, Heavy Use of Chemical Hair Relaxer Linked to Uterine CancerAmong postmenopausal Black women, moderate and heavy use of chemical hair relaxers is associated with an increased risk for uterine cancer, according to a study published online in the upcoming Dec. 15 issue of Environmental Research.Kimberly A. Bertrand, Sc.D., M.P.H., from Slone Epidemiology Center at Boston University, and colleague |
MedScape
28 November at 01.50 AM
Sleep-Disordered Breathing Common After StrokeSleep-disordered breathing remains common after stroke, affecting 60% of patients and showing no decline in prevalence from 2010 to 2023, a new meta-analysis suggested. |
Medpage Today
24 November at 08.00 PM
IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-UpHOUSTON -- Progression-free survival (PFS) in IDH-mutant low-grade glioma remained twice as high in adults who received vorasidenib (Voranigo) after surgery versus placebo, according to a follow-up analysis of a pivotal clinical... |
Medical xPress
23 November at 01.50 PM
RNA editing is the next frontier in gene therapy—here's what you need to knowThe United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision loss in millions of older people worldwide. |
|
HealthDay
22 November at 04.44 PM
Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use DisorderSemaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD), according to a study published online Nov. 13 in JAMA Psychiatry.Markku Lähteenvuo, M.D., Ph.D., from the University of Eastern Finland in Kuopio, and colleagues conducted an observational study in Sweden using data from |
|
Medpage Today
17 November at 10.31 PM
Two Treatments That Don't Work for OsteoarthritisWASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... |
|
MedScape
11 November at 07.56 AM
Scoring System Could Mean Better Access to Lung TransplantScoring system could improve access for hard-to-match candidates due to height and blood type. |
|
|
Medical xPress
07 November at 07.50 AM
How key results could influence health policyThe results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. |
|
Medpage Today
05 November at 07.00 PM
Mpox Cases in Congo May Be StabilizingGOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... |
|
Medical xPress
02 November at 07.40 AM
Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study findsRutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. |
|
MedScape
31 October at 06.30 AM
Report: Rethink Race-Based Adjustments in Clinical ToolsThe slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. |
Newsletter for Healtcare
Join over 1.2M subscribers and receive one weekly email.
